Table 5 Correlation of selected cytokines with cholesterol subfractions in male and female subgroups of healthy controls after controlling for age and BMI (*p < 0.05, **p < 0.01, and ***p < 0.001)
From: Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
Controls | IL-1β | IL-2 | IL-4 | IL-5 | IL-6 | IL-7 | IL-8 | IL-10 | IL-12 | IL-13 | IL-17 | G-CSF | GM-CSF | IFN-γ | TNF-α | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VLDL (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.710 * | NS | NS | |
IDL-A (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | −0.800 * | NS | NS | NS | NS | NS | − 0.790 * | NS | NS | NS | |
IDL-B (mg/dl) | M | −0.928 ** | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
IDL-C (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.791 * | NS | NS | |
LDL1 (mg/dl) | M | NS | NS | NS | NS | NS | NS | 0.857 * | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | −0.717 * | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
LDL2 (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
LDL1–2 (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | −0.719 * | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
LDL3–7 (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
L-HDL (mg/dl) | M | NS | NS | NS | NS | NS | NS | 0.823 * | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.948*** | NS | NS | |
I-HDL (mg/dl) | M | NS | NS | −0.872 * | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.875 * | − 0.821 * |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
S-HDL (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | |
Total HDL (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.758 * | NS | NS |
F | NS | NS | NS | NS | NS | −0.711 * | NS | NS | NS | NS | NS | −0.787 * | −0.940*** | NS | NS | |
Total cholesterol (mg/dl) | M | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
F | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.756 * | −0.844 ** | NS | NS |